Kinetic and structural studies of Mycobacterium tuberculosis dihydroorotate dehydrogenase reveal new insights to class 2 DHODH inhibition.

Vol 2, 2022 - 154150
Poster
Favoritar este trabajo
¿Cómo citar este artículo?
Resúmenes

The enzyme dihydroorotate dehydrogenase (DHODH) present in Mycobacterium tuberculosis1 (MtDHODH) is a  promising target against tuberculosis. MtDHODH obtained after purification was pure with a yield of 12 mg/L of cell culture. The full kinetic characterization was performed with the substrates (dihydroorotate (DHO) and menadione (K3) with KmDHO = 258 ± 17 uM, KmK3 = 145 ± 10 uM, Kcat = 2.69 ± 0.08 (s-1). Unexpectedly, the coenzyme Q0 ( 2,3-dimethoxy-5-methyl-1,4-benzoquinone) was found to inhibit MtDHODH (Ki (Q0) = 138 ± 31 μM). To the best of our knowledge, Q0 is the first dihydroorotate-competitive inhibitor for class 2 DHODHs ever described. The structure of the full MtDHODH was solved by x-ray crystallography and molecular dynamics simulations, along with in silico solvent mapping, allow us to identify that the dynamics of the N-terminal region have a significant impact on the conformation of binding sites for drug-like molecules.

¡Comparte tus ideas o preguntas con los autores!

¿Sabías que el mayor estímulo en el desarrollo científico y cultural es la curiosidad? ¡Deje sus preguntas o sugerencias al autor!

Inicia sesión para interactuar

¿Tiene alguna pregunta o sugerencia? ¡Comparte tus comentarios con los autores!

Instituciones
  • 1 Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), Universidade de São Paulo (USP)
  • 2 Universidade de São Paulo
  • 3 Universidade Estadual Paulista “Júlio de Mesquita Filho” - Campus Araraquara
  • 4 Universidade Estadual Paulista “Júlio de Mesquita Filho”
Eje Temático
  • 1. Strategies in Drug Design
Palabras Clave
Mycobacterium tuberculosis
DHODH
Kinetic
X-ray structure
Dynamics